CST Academy Expands to Buffalo Grove with New Multidisciplinary Therapy Clinic for Children
CST Academy is opening in Buffalo Grove. Full-service pediatric therapy—ABA, speech, OT, PT, diagnostics & more—all under one roof.
'We're excited to bring our multidisciplinary, collaborative model to the community in a space that's built entirely with child development in mind.'— Megan Morien, Chief Clinical Officer at CST Academy
BUFFALO GROVE, IL, UNITED STATES, May 13, 2025 / EINPresswire.com / -- CST Academy, a leading provider of pediatric autism and developmental therapy services in the Chicagoland area, will open a new clinic in Buffalo Grove on June 2, 2025. The new location will expand access to the organization's integrated, family-centered model of care for families in Buffalo Grove and surrounding communities.
The clinic will offer a full continuum of services, including Applied Behavior Analysis (ABA), speech therapy, occupational therapy, physical therapy, diagnostic evaluations, and CST Academy's therapeutic preschool-styled program. Therapy will be available to children across a range of developmental stages, with individualized plans tailored to each child's needs.
'We have heard from so many families in the Buffalo Grove area who are eager for access to high-quality, consistent therapy services,' said Megan Morien, Chief Clinical Officer at CST Academy and a Licensed Behavior Analyst. 'We're excited to bring our multidisciplinary, collaborative model to the community in a space that's built entirely with child development in mind.'
The Buffalo Grove location features a brand-new, state-of-the-art gym, spacious treatment rooms, and environments designed to foster meaningful engagement, learning, and developmental progress. The clinic's layout and programming reflect CST Academy's values of evidence-based care, collaborative clinical teams, and deep investment in each child's growth.
Founded in 2010 as a small in-home speech therapy practice, CST Academy has since grown into a leader in clinic-based autism services, serving families across Chicago and the North Shore. The Buffalo Grove expansion represents the next chapter in that growth.
'We're thrilled to finally open our doors in Buffalo Grove,' said Idar Lamo, CEO of CST Academy. 'We've already supported many local families through diagnostic evaluations, and now we're in a position to continue that care, right in their neighborhood. It's incredibly meaningful for us.'
Families in the Buffalo Grove area have already voiced a strong need for expanded access to high-quality therapy services, and CST Academy is ready to meet that need.
Enrollment is now open, and CST Academy is currently accepting new clients for all services at the Buffalo Grove location.
Families can visit www.cstacademy.com or call 773-620-7800 to learn more.
Samantha Duff
Therapy News
+1 312-722-3256
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
16 hours ago
- CBS News
Rochester football player who collapsed during game graduates high school
The Beaver County football player who collapsed during a game last year graduated from high school this week. Rochester High School's Carter Mason collapsed on the sidelines after taking a hit in the fourth quarter during a game in October 2024 against Shenango. Mason suffered a brain bleed, his family said. On Thursday, he walked across the stage and received his diploma, a milestone his family said they were not sure he'd ever reach. "How far he came, yeah, it's amazing every single day," his mother, Terri Mason, said. "He makes it look easy," she added. "But it's very depressing, very depressing because he can't do everything he used to do and go places like he used to." After spending nearly three months in the hospital, Carter Mason went home and began occupational, physical and speech therapies. His mom said he still struggles with memory loss. "He doesn't know where he's going," she said. "He doesn't know places, people. So, whenever he goes somewhere, he has to have somebody with him at all times." But she said that her son has not let that stop him from achieving his goals. Terri Mason said he went to school for two to three hours per day to graduate with his classmates. "It was so exciting," she said. "The whole auditorium, I think, was just amazed." Terri Mason said Carter Mason will continue therapy for the next two to three years. But she hopes to get him back to doing things independently, with the goal of a full recovery.
Yahoo
2 days ago
- Yahoo
Inspire Autism Names Kristin Hustyi, MA, BCBA as Chief Clinical Officer, Strengthening Its Position as a Leader in Autism Therapy Services
DETROIT, June 5, 2025 /PRNewswire/ -- Inspire Autism, a growing provider of evidence-based therapy for children diagnosed with autism spectrum disorder, announces the appointment of Kristin M. Hustyi, MA, BCBA, as its new Chief Clinical Officer. This strategic addition highlights Inspire Autism's commitment to delivering exceptional outcomes to families across Metro Detroit. Kristin Hustyi brings over 15 years of experience in behavior analysis, clinical innovation, and research leadership to Inspire Autism. She holds a Master of Arts in Applied Behavior Analysis from the University of the Pacific and a Bachelor of Science in Psychology from Western Michigan University. Previously, Hustyi served as Vice President of Research at LittleStar ABA Therapy and National Director of Outcomes at Invo Healthcare. She currently serves as an Adjunct Lecturer at Stanford University School of Medicine. Her clinical work is backed by more than 20 peer-reviewed publications and over 50 national presentations, positioning her as a leading voice in the field. "Inspire Autism has always been dedicated to building a team that delivers high-quality, compassionate, and results-driven care," said Brandon Boudreau, CEO of Inspire Autism. "Kristin's appointment underscores that mission. Her unique blend of clinical experience, research excellence, and thought leadership will be instrumental in elevating the standard of care we offer families." Hustyi will lead Inspire Autism's clinical vision, ensuring the delivery of data-driven therapy rooted in the latest advancements in the field. She will focus on client outcomes, clinician mentorship, and interdisciplinary collaboration with diagnostic professionals and pediatricians throughout Southeast Michigan. "I'm honored to join Inspire Autism at such a pivotal moment in its growth," said Hustyi. "This organization is deeply committed to families, and I look forward to expanding access to individualized services that change lives." Inspire Autism provides early intervention services including Applied Behavior Analysis (ABA), speech therapy, and occupational therapy to children across the autism spectrum. With Kristin Hustyi at the clinical helm, Inspire Autism aims to expand its regional impact and strengthen partnerships with pediatric providers, diagnostic centers, and local communities. About Inspire AutismInspire Autism is an autism spectrum disorder therapy provider specializing in comprehensive services for children. The organization focuses on data-informed outcomes to ensure every child has the opportunity to thrive. Contact:Inspire Autisminfo@ (844) - View original content to download multimedia: SOURCE INSPIRE AUTISM LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
2 days ago
- Bloomberg
Regenxbio's Gene Therapy Helps Kids with Deadly Muscle Disease
Children with a deadly muscle disorder had more control of their bodies after getting an experimental gene therapy from Regenxbio Inc. in a small study. The results foreshadow a potential rivalry with Sarepta Therapeutics Inc. and a critical test for the Trump administration's new drug regulators. The first five children with Duchenne muscular dystrophy to receive a higher dose of Regenxbio's treatment showed 'consistent benefit' after nine months, with improvements in motor function and the time it took to stand, walk and climb, the company said Thursday. It's conducting a larger study involving about 30 patients that it expects to be in full swing by the end of the year, with the potential to file for approval by mid-2026.